Device type · OUT
Intracranial Aneurysm Flow Diverter
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OUT
Neurology
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
1,798
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Intracranial Aneurysm Flow Diverter
- Product code
- OUT
- Device class
- Class III
- Review panel
- Neurology
- Specialty
- Neurology & Neurosurgery, Neurovascular
- FDA record
- Classification database entry for OUT
Latest FDA decisions
P180027 · Decided Dec 16, 2019 · 502 days after receipt
Device type: Intracranial aneurysm flow diverter (OUT) · Neurology & Neurosurgery
- Pipeline Flex Embolization DevicePMA supplement
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
P100018-S015 · Decided Dec 14, 2018 · 534 days after receipt · Panel Track
Device type: Intracranial aneurysm flow diverter (OUT) · Neurology & Neurosurgery
P170024 · Decided Jul 13, 2018 · 347 days after receipt
Device type: Intracranial aneurysm flow diverter (OUT) · Neurology & Neurosurgery
Reports received
1,798
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
1,432
80% of reports
Injury reports
324
18% of reports
Death reports
41
2.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 46 | 25 | 2 | 0 |
| Jan 24 | 90 | 35 | 1 | 0 |
| Feb 24 | 42 | 17 | 3 | 0 |
| Mar 24 | 92 | 29 | 1 | 0 |
| Apr 24 | 80 | 44 | 12 | 0 |
| May 24 | 71 | 33 | 5 | 0 |
| Jun 24 | 75 | 13 | 1 | 0 |
| Jul 24 | 77 | 21 | 2 | 0 |
| Aug 24 | 74 | 30 | 3 | 0 |
| Sep 24 | 77 | 27 | 2 | 0 |
| Oct 24 | 89 | 57 | 12 | 0 |
| Nov 24 | 58 | 23 | 1 | 0 |
| Dec 24 | 99 | 29 | 1 | 0 |
| Jan 25 | 106 | 32 | 5 | 0 |
| Feb 25 | 155 | 31 | 3 | 0 |
| Mar 25 | 96 | 51 | 12 | 0 |
| Apr 25 | 98 | 37 | 5 | 0 |
| May 25 | 75 | 28 | 2 | 0 |
| Jun 25 | 82 | 33 | 7 | 0 |
| Jul 25 | 115 | 15 | 0 | 0 |
| Aug 25 | 98 | 25 | 3 | 0 |
| Sep 25 | 87 | 26 | 1 | 0 |
| Oct 25 | 112 | 24 | 7 | 0 |
| Nov 25 | 96 | 20 | 0 | 0 |
| Dec 25 | 129 | 27 | 0 | 0 |
| Jan 26 | 151 | 16 | 3 | 0 |
| Feb 26 | 74 | 24 | 3 | 0 |
| Mar 26 | 131 | 53 | 11 | 0 |
| Apr 26 | 122 | 35 | 3 | 0 |
| May 26 | 145 | 14 | 1 | 0 |
| Jun 26 | 119 | 29 | 0 | 0 |
| Jul 26 | 142 | 20 | 1 | 0 |
| Aug 26 | 109 | 30 | 10 | 0 |
| Sep 26 | 114 | 39 | 8 | 1 |
| Oct 26 | 100 | 17 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Activation Failure1,066
- Physical Resistance/Sticking508
- Material Deformation446
- Retraction Problem331
- Adverse Event Without Identified Device or Use Problem259
- Unintended Movement136
- Use of Device Problem127
- Improper or Incorrect Procedure or Method109
- Unintended Ejection108
- Activation, Positioning or Separation Problem93
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1,459
- Thrombosis/Thrombus89
- Aneurysm84
- Stenosis78
- Ischemia Stroke76
- Obstruction/Occlusion71
- Intracranial Hemorrhage45
- Nervous System Injury34
- Ruptured Aneurysm33
- Stroke/CVA30
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3326-2026 · Started Jun 25, 2026 · Posted by FDA Sep 28, 2026
Reason given: Due to incorrect label/product dimensions. Product is supposed to be 3.00 mm in diameter, but unit is packaging was a 2.50 mm in diameter.
Cause as FDA categorized it: Under Investigation by firm
- Pipeline Flex Embolization Device with Shield Technology, 3.00 mm x 12 mm 027 REF PED2-300-12. Intracranial aneurysm flow diverterOpen, Classified
Z-2773-2026 · Started Jun 8, 2026 · Posted by FDA Jul 22, 2026
Reason given: Incorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.
Cause as FDA categorized it: Labeling Change Control
- Pipeline Flex Embolization Device with Shield Technology, 3.00 mm x 20 mm 027 REF PED2-300-20. Intracranial aneurysm flow diverterOpen, Classified
Z-2774-2026 · Started Jun 8, 2026 · Posted by FDA Jul 22, 2026
Reason given: Incorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.
Cause as FDA categorized it: Labeling Change Control
Z-0108-2026 · Started Sep 5, 2025 · Posted by FDA Oct 10, 2025
Reason given: Flow diverter may have a manufacturing issue related to the tantalum length and/or tantalum attachment pattern, which may lead the device to be incompletely open or not properly apposed to the vessel wall, which may necessitate device recapture and withdrawal of the delivery system and microcatheter together....
Cause as FDA categorized it: Device Design
Z-1245-2025 · Started Jan 30, 2025 · Posted by FDA Mar 5, 2025
Reason given: Use of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or...
Cause as FDA categorized it: Device Design
Z-1246-2025 · Started Jan 30, 2025 · Posted by FDA Mar 5, 2025
Reason given: Use of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or...
Cause as FDA categorized it: Device Design
Z-2238-2023 · Started Jun 7, 2023 · Posted by FDA Jul 27, 2023
Reason given: Intracranial aneurysm flow diverter device may be manufactured with an incorrect inner stent length and may not perform as intended.
Cause as FDA categorized it: Process control
- Pipeline Flex Embolization DeviceOpen, Classified
Z-2402-2021 · Started Jul 13, 2021
Reason given: Due to potential push wire fractures in the delivery system during use. The issue presents as a fracture in the spiral cut area of the Hypotube.
Cause as FDA categorized it: Device Design
Showing the 8 newest of 14 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.